{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:06:11Z","timestamp":1790651171888,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013700\/1"],"award-info":[{"award-number":["MR\/N013700\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\u2019s College London"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["APP400704"],"award-info":[{"award-number":["APP400704"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Regulation of brain glutamate is closely related to brain energy metabolism. Changes in both central glutamatergic function and peripheral energy metabolism have been implicated in psychosis risk, onset and long-term illness, but there is a lack of empirical evidence to link these processes. We investigated the relationships between glutamate and\n                    <jats:italic>N<\/jats:italic>\n                    -acetyl-aspartate (NAA, a potential marker of neuronal metabolic integrity) in the anterior cingulate cortex (ACC), measured using proton magnetic resonance spectroscopy (\n                    <jats:sup>1<\/jats:sup>\n                    H-MRS), and peripheral markers of energy metabolism (mitochondrial complex I\u2013V content, pyruvate and lactate) in individuals either at clinical high risk for psychosis or in the first episode of psychosis (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200936) and healthy controls (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200920). ACC Glx (glutamate\u2009+\u2009glutamine) levels were positively related with principal components relating to mitochondrial complex content, and this relationship did not differ between groups. These findings are consistent with the importance of mitochondrial ATP generation in regulating glutamatergic neurotransmission. While we did not find evidence that this relationship is disrupted in clinical high risk or first episode psychosis, further work is required to understand the mechanisms linking glutamate and energy metabolism in psychosis, including studies in larger cohorts, later stages of illness or in individuals with greater illness burden.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-22845-y","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:35:48Z","timestamp":1764077748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glutamate, NAA, and energy metabolism in clinical high risk and first episode psychosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Bridget","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Kempton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shue Kit","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Egerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"22845_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","volume":"70","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli, P. et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 70, 107\u2013120 (2013).","journal-title":"JAMA Psychiatry"},{"key":"22845_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamapsychiatry.2021.0830","volume":"78","author":"GS De Pablo","year":"2021","unstructured":"De Pablo, G. S. et al. Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis. JAMA Psychiatry. 78, 970\u2013978 (2021).","journal-title":"JAMA Psychiatry"},{"key":"22845_CR3","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/s41380-021-01374-w","volume":"27","author":"M Cuenod","year":"2022","unstructured":"Cuenod, M. et al. Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia. Mol. Psychiatry. 27, 1886\u20131897 (2022).","journal-title":"Mol. Psychiatry"},{"key":"22845_CR4","doi-asserted-by":"publisher","first-page":"116220","DOI":"10.1016\/j.psychres.2024.116220","volume":"328","author":"Z Sarnyai","year":"2024","unstructured":"Sarnyai, Z. &  Ben-Shachar, D. Schizophrenia a disease of impaired dynamic metabolic flexibility: A new mechanistic framework. Psychiatry Res. 328, 116220 (2024).","journal-title":"Psychiatry Res."},{"key":"22845_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11920-023-01457-1","volume":"25","author":"A Stein","year":"2023","unstructured":"Stein, A., Zhu, C., Du, F. & \u00d6ng\u00fcr, D. Magnetic resonance spectroscopy studies of brain energy metabolism in schizophrenia: progression from prodrome to chronic psychosis. Curr. Psychiatry Rep. 25, 659\u2013669 (2023).","journal-title":"Curr. Psychiatry Rep."},{"key":"22845_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.schres.2020.09.013","volume":"223","author":"A Egerton","year":"2020","unstructured":"Egerton, A. et al. Glutamate in schizophrenia: neurodevelopmental perspectives and drug development. Schizophr. Res. 223, 59\u201370 (2020).","journal-title":"Schizophr. Res."},{"key":"22845_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon, R. A., Krystal, J. H. & Howes, O. D. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 19, 15\u201333 (2020).","journal-title":"World Psychiatry"},{"key":"22845_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-45096-4_2","volume":"13","author":"L Hertz","year":"2016","unstructured":"Hertz, L. & Rothman, D. L. Glucose, lactate, \u03b2-hydroxybutyrate, acetate, GABA, and succinate as substrates for synthesis of glutamate and GABA in the glutamine\u2013glutamate\/GABA cycle. Adv. Neurobiol. 13, 9\u201342 (2016).","journal-title":"Adv. Neurobiol."},{"key":"22845_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1073\/pnas.95.1.316","volume":"95","author":"NR Sibson","year":"1998","unstructured":"Sibson, N. R. et al. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. USA. 95, 316\u2013321 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22845_CR10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1177\/0271678X17708691","volume":"38","author":"Y Yu","year":"2018","unstructured":"Yu, Y., Herman, P., Rothman, D. L., Agarwal, D. & Hyder, F. Evaluating the Gray and white matter energy budgets of human brain function. J. Cereb. Blood Flow. Metab. 38, 1339\u20131353 (2018).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"22845_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell, D. & Laughlin, S. B. An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow. Metab. 21, 1133\u20131145 (2001).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"22845_CR12","doi-asserted-by":"publisher","first-page":"108727","DOI":"10.1016\/j.neuropharm.2021.108727","volume":"198","author":"J Lezmy","year":"2021","unstructured":"Lezmy, J., Harris, J. J. & Attwell, D. Optimising the energetic cost of the glutamatergic synapse. Neuropharmacology 198, 108727 (2021).","journal-title":"Neuropharmacology"},{"key":"22845_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-4173(82)90013-1","volume":"683","author":"D Nicholls","year":"1982","unstructured":"Nicholls, D. & \u00c5kerman, K. Mitochondrial calcium transport. Biochim. Biophys. Acta Rev. Bioenerg. 683, 57\u201388 (1982).","journal-title":"Biophys. Acta Rev. Bioenerg"},{"key":"22845_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0079-6123(08)61978-0","volume":"63","author":"DG Nicholls","year":"1985","unstructured":"Nicholls, D. G. A role for the mitochondrion in the protection of cells against calcium overload? Prog. Brain Res. 63, 97\u2013106 (1985).","journal-title":"Brain Res."},{"key":"22845_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pharma.2022.10.003","volume":"81","author":"KD Tiwari","year":"2023","unstructured":"Tiwari, K. D. et al. Effects of high glutamate concentrations on mitochondria of human neuroblastoma SH-SY5Y cells. Ann. Pharm. Fr. 81, 457\u2013465 (2023).","journal-title":"Ann. Pharm. Fr."},{"key":"22845_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10541-005-0160-x","volume":"70","author":"NK Isaev","year":"2005","unstructured":"Isaev, N. K., Andreeva, N. A., Stel\u2019mashuk, E. V. & Zorov, D. B. Role of mitochondria in the mechanisms of glutamate toxicity. Biochem. (Moscow). 70, 611\u2013618 (2005).","journal-title":"Biochem. (Moscow)"},{"key":"22845_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jnr.10043","volume":"66","author":"J Ros","year":"2001","unstructured":"Ros, J., Pecinska, N., Alessandri, B., Landolt, H. & Fillenz, M. Lactate reduces glutamate-induced neurotoxicity in rat cortex. J. Neurosci. Res. 66, 790\u2013794 (2001).","journal-title":"J. Neurosci. Res."},{"key":"22845_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2010.04.078","volume":"478","author":"Y Izumi","year":"2010","unstructured":"Izumi, Y. & Zorumski, C. F. Neuroprotective effects of pyruvate following NMDA-mediated excitotoxic insults in hippocampal slices. Neurosci. Lett. 478, 131\u2013135 (2010).","journal-title":"Neurosci. Lett."},{"key":"22845_CR19","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/s41598-018-24355-6","volume":"8","author":"T Da Silva","year":"2018","unstructured":"Da Silva, T. et al. Mitochondrial function in individuals at clinical high risk for psychosis. Sci. Rep. 8, 6216 (2018).","journal-title":"Sci. Rep."},{"key":"22845_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","volume":"78","author":"K Merritt","year":"2021","unstructured":"Merritt, K. et al. Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of individual participant-level data. JAMA Psychiatry. 78, 667\u2013681 (2021).","journal-title":"JAMA Psychiatry"},{"key":"22845_CR21","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41380-023-01991-7","volume":"28","author":"K Merritt","year":"2023","unstructured":"Merritt, K. et al. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis. Mol. Psychiatry. 28, 2039\u20132048 (2023).","journal-title":"Mol. Psychiatry"},{"key":"22845_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41380-021-01297-6","volume":"27","author":"T Nakahara","year":"2022","unstructured":"Nakahara, T. et al. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies. Mol. Psychiatry. 27, 744\u2013757 (2022).","journal-title":"Mol. Psychiatry"},{"key":"22845_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","volume":"73","author":"K Merritt","year":"2016","unstructured":"Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J. & McGuire, P. K. Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies. JAMA Psychiatry. 73, 665\u2013674 (2016).","journal-title":"JAMA Psychiatry"},{"key":"22845_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","volume":"39","author":"CD Rae","year":"2014","unstructured":"Rae, C. D. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem. Res. 39, 1\u201336 (2014).","journal-title":"Neurochem. Res."},{"key":"22845_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","volume":"81","author":"JR Moffett","year":"2007","unstructured":"Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N. & Namboodiri, A. M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89\u2013131 (2007).","journal-title":"Prog. Neurobiol."},{"key":"22845_CR26","doi-asserted-by":"crossref","unstructured":"Maddock, R. J. & Buonocore, M. H. MR spectroscopic studies of the brain in psychiatric disorders. In Brain Imaging in Behavioral Neuroscience, 199\u2013251 (2012).","DOI":"10.1007\/7854_2011_197"},{"key":"22845_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000017321","volume":"20","author":"JB Clark","year":"1998","unstructured":"Clark, J. B. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20, 271 (1998).","journal-title":"Dev. Neurosci."},{"key":"22845_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biopsych.2010.10.004","volume":"69","author":"S Brugger","year":"2011","unstructured":"Brugger, S., Davis, J. M., Leucht, S. & Stone, J. M. Proton magnetic resonance spectroscopy and illness stage in schizophrenia\u2014a systematic review and meta-analysis. Biol. Psychiatry. 69, 495\u2013503 (2011).","journal-title":"Biol. Psychiatry"},{"key":"22845_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fpsyt.2013.00099","volume":"4","author":"M Mondino","year":"2013","unstructured":"Mondino, M., Brunelin, J. & Saoud, M. N-acetyl-aspartate level is decreased in the prefrontal cortex in subjects at-risk for schizophrenia. Front. Psychiatry. 4, 99 (2013).","journal-title":"Front. Psychiatry"},{"key":"22845_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neubiorev.2020.10.001","volume":"119","author":"TS Whitehurst","year":"2020","unstructured":"Whitehurst, T. S. et al. Proton magnetic resonance spectroscopy of N-acetyl aspartate in chronic schizophrenia, first episode of psychosis and high-risk of psychosis: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 119, 255\u2013267 (2020).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"22845_CR31","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41380-021-01313-9","volume":"27","author":"I Khadimallah","year":"2022","unstructured":"Khadimallah, I. et al. Mitochondrial, Exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia. Mol. Psychiatry. 27, 1192\u20131204 (2022).","journal-title":"Mol. Psychiatry"},{"key":"22845_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1461145799001649","volume":"2","author":"D Ben-Shachar","year":"1999","unstructured":"Ben-Shachar, D. et al. Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int. J. Neuropsychopharmacol. 2, 245\u2013253 (1999).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"22845_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.mp.4001116","volume":"7","author":"N Dror","year":"2002","unstructured":"Dror, N. et al. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol. Psychiatry. 7, 995\u20131001 (2002).","journal-title":"Mol. Psychiatry"},{"key":"22845_CR34","doi-asserted-by":"publisher","first-page":"12695","DOI":"10.1038\/s41598-019-49180-3","volume":"9","author":"A Wu","year":"2019","unstructured":"Wu, A. et al. Validating mitochondrial electron transport chain content in individuals at clinical high risk for psychosis. Sci. Rep. 9, 12695 (2019).","journal-title":"Sci. Rep."},{"key":"22845_CR35","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1371\/journal.pone.0000756","volume":"2","author":"JTJ Huang","year":"2007","unstructured":"Huang, J. T. J. et al. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One. 2, e756 (2007).","journal-title":"PLoS One"},{"key":"22845_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/eip.12866","volume":"14","author":"M Onozato","year":"2020","unstructured":"Onozato, M. et al. Serum D- and L\u2010lactate, pyruvate and glucose levels in individuals with at\u2010risk mental state and correlations with clinical symptoms. Early Interv. Psychiatry. 14, 410\u2013417 (2020).","journal-title":"Early Interv. Psychiatry"},{"key":"22845_CR37","doi-asserted-by":"crossref","unstructured":"Jiang, J. et al. Leukocyte proteomic profiling in first-episode schizophrenia patients: does oxidative stress play central roles in the pathophysiology network of schizophrenia? (2019).","DOI":"10.1089\/ars.2019.7805"},{"key":"22845_CR38","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fpsyt.2020.00764","volume":"11","author":"JJ Watts","year":"2020","unstructured":"Watts, J. J. et al. Evidence that cannabis exposure, abuse, and dependence are related to glutamate metabolism and glial function in the anterior cingulate cortex: a 1H-magnetic resonance spectroscopy study. Front. Psychiatry. 11, 764 (2020).","journal-title":"Front. Psychiatry"},{"key":"22845_CR39","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopsych.2021.06.021","volume":"90","author":"T Da Silva","year":"2021","unstructured":"Da Silva, T. et al. Genetically predicted brain C4A expression is associated with TSPO and hippocampal morphology. Biol. Psychiatry. 90, 652\u2013660 (2021).","journal-title":"Biol. Psychiatry"},{"key":"22845_CR40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","volume":"29","author":"TJ Miller","year":"2003","unstructured":"Miller, T. J. et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 29, 703\u2013715 (2003).","journal-title":"Schizophr. Bull."},{"key":"22845_CR41","doi-asserted-by":"crossref","unstructured":"First, M. B., Spitzer, R. L., Gibbon, M. & Williams, J. B. W. Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Patient Edition (SCID-I\/P, Version 2.0) (Biometric Research Department, 1995).","DOI":"10.1037\/t07827-000"},{"key":"22845_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr. Bull."},{"key":"22845_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","volume":"36","author":"RC Hall","year":"1995","unstructured":"Hall, R. C. Global assessment of functioning: a modified scale. Psychosomatics 36, 267\u2013275 (1995).","journal-title":"Psychosomatics"},{"key":"22845_CR44","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/archgenpsychiatry.2009.115","volume":"66","author":"SA Schobel","year":"2009","unstructured":"Schobel, S. A. et al. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch. Gen. Psychiatry. 66, 938\u2013946 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"22845_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher, S. W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30, 672\u2013679 (1993).","journal-title":"Magn. Reson. Med."},{"key":"22845_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/schbul\/sbaa128","volume":"47","author":"A Egerton","year":"2021","unstructured":"Egerton, A. et al. Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: a multicenter positron emission tomography and magnetic resonance spectroscopy study (STRATA). Schizophr. Bull. 47, 505\u2013516 (2021).","journal-title":"Schizophr. Bull."},{"key":"22845_CR47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mrm.1910300405","volume":"30","author":"R Kreis","year":"1993","unstructured":"Kreis, R., Ernst, T. & Ross, B. D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn. Reson. Med. 30, 424\u2013437 (1993).","journal-title":"Magn. Reson. Med."},{"key":"22845_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/mrm.20901","volume":"55","author":"C Gasparovic","year":"2006","unstructured":"Gasparovic, C. et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn. Reson. Med. 55, 1219\u20131226 (2006).","journal-title":"Magn. Reson. Med."},{"key":"22845_CR49","unstructured":"Posit Team. RStudio: Integrated development environment for R (Version 2024.4.2.764). Posit Software, PBC (2024). https:\/\/posit.co\/"},{"key":"22845_CR50","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open. Source Softw. 4, 1686 (2019).","journal-title":"J. Open. Source Softw."},{"key":"22845_CR51","unstructured":"Gordon, M. ppcor: an R package for a fast calculation to semipartial and partial correlations. R package version 1.1 (2019)."},{"key":"22845_CR52","unstructured":"Fox, J., Weisberg, S. & An, R. Companion To Applied Regression, 3rd edn (Sage, 2019)."},{"key":"22845_CR53","unstructured":"Canty, A. & Ripley, B. D. boot: Bootstrap R (S-Plus) functions. R package version 1.3\u201328 (2022)."},{"key":"22845_CR54","unstructured":"Harrell, F. E. Jr. Hmisc: Harrell miscellaneous. R package version 5.1-3 (2024)."},{"key":"22845_CR55","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"22845_CR56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neubiorev.2014.11.005","volume":"48","author":"A Rajasekaran","year":"2015","unstructured":"Rajasekaran, A., Venkatasubramanian, G., Berk, M. & Debnath, M. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci. Biobehav. Rev. 48, 10\u201321 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"22845_CR57","doi-asserted-by":"publisher","first-page":"E367","DOI":"10.1503\/jpn.240094","volume":"49","author":"L Fan","year":"2024","unstructured":"Fan, L. et al. Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex. J. Psychiatry Neurosci. 49, E367\u2013E376 (2024).","journal-title":"J. Psychiatry Neurosci."},{"key":"22845_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/wps.20893","volume":"20","author":"RA McCutcheon","year":"2021","unstructured":"McCutcheon, R. A., Merritt, K. & Howes, O. D. Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls. World Psychiatry. 20, 405\u2013416 (2021).","journal-title":"World Psychiatry"},{"key":"22845_CR59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1001\/jamapsychiatry.2018.3637","volume":"76","author":"AM Wang","year":"2019","unstructured":"Wang, A. M. et al. Assessing brain metabolism with 7-T proton magnetic resonance spectroscopy in patients with first-episode psychosis. JAMA Psychiatry. 76, 314\u2013323 (2019).","journal-title":"JAMA Psychiatry"},{"key":"22845_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/schbul\/sbx190","volume":"45","author":"MA Reid","year":"2019","unstructured":"Reid, M. A. et al. 7T proton magnetic resonance spectroscopy of the anterior cingulate cortex in first-episode schizophrenia. Schizophr. Bull. 45, 180\u2013189 (2019).","journal-title":"Schizophr. Bull."},{"key":"22845_CR61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41398-021-01477-6","volume":"11","author":"BR Godlewska","year":"2021","unstructured":"Godlewska, B. R. et al. Brain glutamate concentration in men with early psychosis: a magnetic resonance spectroscopy case\u2013control study at 7 T. Transl. Psychiatry. 11, 367 (2021).","journal-title":"Transl. Psychiatry"},{"key":"22845_CR62","doi-asserted-by":"publisher","first-page":"sgaa072","DOI":"10.1093\/schizbullopen\/sgaa072","volume":"2","author":"P Jeon","year":"2021","unstructured":"Jeon, P. et al. Progressive changes in glutamate concentration in early stages of schizophrenia: a longitudinal 7-Tesla MRS study. Schizophr. Bull. Open. 2, sgaa072 (2021).","journal-title":"Schizophr. Bull. Open."},{"key":"22845_CR63","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.neuropharm.2021.108719","volume":"196","author":"JV Andersen","year":"2021","unstructured":"Andersen, J. V. et al. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology 196, 108719 (2021).","journal-title":"Neuropharmacology"},{"key":"22845_CR64","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/ijms25042294","volume":"25","author":"W Krzy\u015bciak","year":"2024","unstructured":"Krzy\u015bciak, W. et al. Association of blood metabolomics biomarkers with brain metabolites and patient-reported outcomes as a new approach in individualized diagnosis of schizophrenia. Int. J. Mol. Sci. 25, 2294 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"22845_CR65","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1038\/tp.2016.239","volume":"6","author":"LM Rowland","year":"2016","unstructured":"Rowland, L. M. et al. Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study. Transl. Psychiatry. 6, e967 (2016).","journal-title":"Transl. Psychiatry"},{"key":"22845_CR66","doi-asserted-by":"publisher","first-page":"656459","DOI":"10.3389\/fpsyt.2021.656459","volume":"12","author":"SA Wijtenburg","year":"2021","unstructured":"Wijtenburg, S. A. et al. Metabolite alterations in adults with schizophrenia, first degree relatives, and healthy controls: a multi-region 7T MRS study. Front. Psychiatry. 12, 656459 (2021).","journal-title":"Front. Psychiatry"},{"key":"22845_CR67","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s41380-023-01969-5","volume":"28","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study. Mol. Psychiatry. 28, 2018\u20132029 (2023).","journal-title":"Mol. Psychiatry"},{"key":"22845_CR68","doi-asserted-by":"crossref","unstructured":"Dean, B., Thomas, N., Scarr, E. & Udawela, M. Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia. Transl. Psychiatry 6, e949 (2016).","DOI":"10.1038\/tp.2016.226"},{"key":"22845_CR69","doi-asserted-by":"publisher","first-page":"8358","DOI":"10.3390\/ijms22168358","volume":"22","author":"HJ Park","year":"2021","unstructured":"Park, H. J., Choi, I. & Leem, K. H. Decreased brain pH and pathophysiology in schizophrenia. Int. J. Mol. Sci. 22, 8358 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"22845_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.pscychresns.2015.06.003","volume":"233","author":"K Dempster","year":"2015","unstructured":"Dempster, K. et al. Glutamatergic metabolite correlations with neuropsychological tests in first episode schizophrenia. Psychiatry Res. Neuroimaging. 233, 180\u2013185 (2015).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"22845_CR71","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.neuroimage.2009.10.031","volume":"49","author":"Y Shirayama","year":"2010","unstructured":"Shirayama, Y. et al. Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage 49, 2783\u20132790 (2010).","journal-title":"Neuroimage"},{"key":"22845_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0924-977X(02)00003-2","volume":"12","author":"DF Braus","year":"2002","unstructured":"Braus, D. F. et al. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur. Neuropsychopharmacol. 12, 145\u2013152 (2002).","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl 1","key":"22845_CR73","first-page":"11","volume":"13","author":"B Gali\u0144ska","year":"2007","unstructured":"Gali\u0144ska, B. et al. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia. Med. Sci. Monit. 13 (Suppl 1), 11\u201316 (2007).","journal-title":"Med. Sci. Monit."},{"key":"22845_CR74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.schres.2020.02.001","volume":"249","author":"M Reddy-Thootkur","year":"2022","unstructured":"Reddy-Thootkur, M., Kraguljac, N. V. & Lahti, A. C. The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders \u2013 a systematic review of magnetic resonance spectroscopy studies. Schizophr. Res. 249, 74\u201384 (2022).","journal-title":"Schizophr. Res."},{"key":"22845_CR75","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1111\/j.1471-4159.2008.05524.x","volume":"106","author":"P Arun","year":"2008","unstructured":"Arun, P., Madhavarao, C. N., Moffett, J. R. & Namboodiri, A. M. Antipsychotic drugs increase N-acetylaspartate and N\u2010acetylaspartylglutamate in SH\u2010SY5Y human neuroblastoma cells. J. Neurochem. 106, 1669\u20131680 (2008).","journal-title":"J. Neurochem"},{"key":"22845_CR76","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0920-9964(02)00210-4","volume":"58","author":"JR Bustillo","year":"2002","unstructured":"Bustillo, J. R. et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr. Res. 58, 313\u2013321 (2002).","journal-title":"Schizophr. Res."},{"key":"22845_CR77","doi-asserted-by":"publisher","first-page":"e1147","DOI":"10.1038\/tp.2017.124","volume":"7","author":"A Egerton","year":"2017","unstructured":"Egerton, A., Modinos, G., Ferrera, D. & McGuire, P. Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis. Transl. Psychiatry. 7, e1147 (2017).","journal-title":"Transl. Psychiatry"},{"key":"22845_CR78","first-page":"119","volume":"8","author":"N Goto","year":"2012","unstructured":"Goto, N. et al. Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia. Neuropsychiatr. Dis. Treat. 8, 119 (2012).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"22845_CR79","doi-asserted-by":"publisher","first-page":"105862","DOI":"10.1016\/j.dib.2020.105862","volume":"31","author":"M Kubota","year":"2020","unstructured":"Kubota, M., Moriguchi, S., Takahata, K., Nakajima, S. & Horita, N. Treatment effects on neurometabolite levels in schizophrenia: a meta-analysis dataset of proton magnetic resonance spectroscopy. Data Brief. 31, 105862 (2020).","journal-title":"Data Brief."},{"key":"22845_CR80","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/JCP.0b013e318054753e","volume":"27","author":"J Casademont","year":"2007","unstructured":"Casademont, J. et al. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients. J. Clin. Psychopharmacol. 27, 284\u2013288 (2007).","journal-title":"J. Clin. Psychopharmacol."},{"key":"22845_CR81","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jneumeth.2007.11.017","volume":"169","author":"ND Halim","year":"2008","unstructured":"Halim, N. D. et al. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. J. Neurosci. Methods. 169, 208\u2013213 (2008).","journal-title":"J. Neurosci. Methods"},{"key":"22845_CR82","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker","year":"1989","unstructured":"Parker, W. D., Boyson, S. J. & Parks, J. K. Abnormalities of the electron transport chain in idiopathic parkinson\u2019s disease. Ann. Neurol. 26, 719\u2013723 (1989).","journal-title":"Ann. Neurol."},{"key":"22845_CR83","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","volume":"55","author":"A Schapira","year":"1990","unstructured":"Schapira, A. et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in parkinson\u2019s disease. J. Neurochem. 55, 2142\u20132145 (1990).","journal-title":"J. Neurochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:03:34Z","timestamp":1764165814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22845-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7052494\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.E. has received consultancy fees from Leal Therapeutics. All other authors declare no conflicts of interest related to the subject of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42031"}}